• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和验证尿液 microRNA 生物标志物谱作为一种工具,用于在中国人群中早期检测前列腺癌。

Development and validation of a urinary microRNA biomarker panel as a tool for early detection of prostate cancer in a Chinese population.

机构信息

The second Affiliated Hospital of Medical College of Zhejiang University, Hangzhou, Zhejiang, China.

Hangzhou Ninth People's Hospital, Hangzhou, Zhejiang, China.

出版信息

Biomarkers. 2023 Jun;28(4):372-378. doi: 10.1080/1354750X.2023.2166587. Epub 2023 Apr 26.

DOI:10.1080/1354750X.2023.2166587
PMID:37185057
Abstract

INTRODUCTION

Urinary microRNAs (miRNAs) may serve as promising biomarkers for non-invasive early detection of prostate cancer (PCa). We aimed to identify multi-miRNA urinary biomarker panel for early detection of PCa.

METHODS

Urine samples from 83 PCa patients and 88 healthy control subjects in a Chinese population were collected for miRNA profiling. The absolute expression of 360 unique miRNAs were measured in each sample using a highly sensitive and robust RT-qPCR workflow. Candidate urinary miRNA biomarkers were identified based on differential expression between PCa patients and healthy controls. Multi-miRNA biomarker panels were optimised for detection of PCa using three regression algorithms (Lasso, Stepwise, Exhaustive) to identify an optimal biomarker panel with best detection performance and least number of miRNAs.

RESULTS

A total of 312 miRNAs were detected in urine samples, 10 candidate urinary miRNA biomarkers differentially expressed between PCa and healthy samples were identified. A panel comprising these 10 miRNAs detected PCa with an area under the curve (AUC) of 0.738. Optimization of multi-miRNA panels resulted in a 6-miRNA biomarker panel (hsa-miR-375, hsa-miR-520d-5p, hsa-miR-199b-5p, hsa-miR-518e-5p, hsa-miR-31-3p and hsa-miR-4306) that had an AUC of 0.750.

CONCLUSION

We identified a urinary miRNA biomarker panel for early detection of PCa in a Chinese population.

摘要

简介

尿液 microRNAs(miRNAs)可能成为前列腺癌(PCa)非侵入性早期检测有前途的生物标志物。我们旨在确定用于早期检测 PCa 的多 miRNA 尿液生物标志物。

方法

在中国人群中收集了 83 例 PCa 患者和 88 例健康对照者的尿液样本进行 miRNA 谱分析。使用高度敏感和稳健的 RT-qPCR 工作流程测量每个样本中 360 个独特 miRNA 的绝对表达。基于 PCa 患者与健康对照之间的差异表达,确定候选尿液 miRNA 生物标志物。使用三种回归算法(lasso、逐步、穷尽)优化多 miRNA 生物标志物面板,以确定具有最佳检测性能和最少 miRNA 数的最佳生物标志物面板。

结果

共检测到 312 个 miRNA,在 PCa 和健康样本之间有 10 个候选尿液 miRNA 生物标志物差异表达。由这 10 个 miRNA 组成的面板检测 PCa 的曲线下面积(AUC)为 0.738。多 miRNA 面板的优化产生了一个由 6 个 miRNA 生物标志物组成的面板(hsa-miR-375、hsa-miR-520d-5p、hsa-miR-199b-5p、hsa-miR-518e-5p、hsa-miR-31-3p 和 hsa-miR-4306),其 AUC 为 0.750。

结论

我们在中国人群中确定了用于早期检测 PCa 的尿液 miRNA 生物标志物。

相似文献

1
Development and validation of a urinary microRNA biomarker panel as a tool for early detection of prostate cancer in a Chinese population.开发和验证尿液 microRNA 生物标志物谱作为一种工具,用于在中国人群中早期检测前列腺癌。
Biomarkers. 2023 Jun;28(4):372-378. doi: 10.1080/1354750X.2023.2166587. Epub 2023 Apr 26.
2
Identification of Key MicroRNAs and Mechanisms in Prostate Cancer Evolution Based on Biomarker Prioritization Model and Carcinogenic Survey.基于生物标志物优先级模型和致癌性调查的前列腺癌演变中关键 microRNA 及其机制的鉴定
Front Genet. 2021 Jan 15;11:596826. doi: 10.3389/fgene.2020.596826. eCollection 2020.
3
Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone.尿 hsv2-miR-H9 与 hsa-miR-3659 的比值是鉴别前列腺特异性抗原灰区患者前列腺癌与良性前列腺增生的有效标志物。
Investig Clin Urol. 2022 Mar;63(2):238-244. doi: 10.4111/icu.20210493.
4
Detection of miRNAs in urine of prostate cancer patients.前列腺癌患者尿液中微小RNA的检测
Medicina (Kaunas). 2016;52(2):116-24. doi: 10.1016/j.medici.2016.02.007. Epub 2016 Mar 11.
5
Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.血浆 microRNAs 作为早期胃癌早期检测的潜在新型生物标志物。
World J Gastroenterol. 2019 Apr 7;25(13):1580-1591. doi: 10.3748/wjg.v25.i13.1580.
6
The value of a three-microRNA panel in serum for prostate cancer screening.三 miRNA 标志物联合检测在血清前列腺癌筛查中的价值。
Int J Biol Markers. 2024 Mar;39(1):70-79. doi: 10.1177/03936155231213660. Epub 2023 Nov 13.
7
Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancer.尿 microRNA-1913 至 microRNA-3659 表达比值作为前列腺癌的一种非侵入性诊断生物标志物。
Investig Clin Urol. 2021 May;62(3):340-348. doi: 10.4111/icu.20200488. Epub 2021 Mar 16.
8
MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.基于静水压过滤透析法检测尿液细胞外囊泡中的MiR-145可提高前列腺癌的诊断效率。
Prostate. 2017 Jul;77(10):1167-1175. doi: 10.1002/pros.23376. Epub 2017 Jun 15.
9
OncoUroMiR: Circulating miRNAs for Detection and Discrimination of the Main Urological Cancers Using a ddPCR-Based Approach.OncoUroMiR:一种基于 ddPCR 的方法,用于检测和区分主要泌尿系统癌症的循环 miRNA。
Int J Mol Sci. 2023 Sep 9;24(18):13890. doi: 10.3390/ijms241813890.
10
Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.外泌体和非外泌体来源的尿液微小RNA在前列腺癌检测和预后中的作用
Prostate. 2017 May;77(6):573-583. doi: 10.1002/pros.23295. Epub 2016 Dec 19.